ProfileGDS4718 / 222221_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 86% 83% 86% 82% 79% 79% 86% 84% 84% 84% 88% 84% 78% 76% 81% 80% 80% 81% 75% 87% 86% 81% 80% 83% 82% 81% 78% 80% 81% 79% 70% 87% 86% 76% 77% 85% 84% 83% 82% 83% 76% 77% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.1686483
GSM549102patient 115, normal, homogenized [OPG study]8.5346186
GSM549104patient 119, normal, homogenized [OPG study]8.2675983
GSM549108patient 138, normal, homogenized [OPG study]8.4489986
GSM549119patient 077, normal, homogenized [OPG study]8.0779382
GSM549133patient 032, cancer, homogenized [OPG study]7.9299479
GSM549139patient 042, cancer, homogenized [OPG study]7.7537579
GSM549099patient 107, normal, homogenized [OPG study]8.4871586
GSM549109patient 139, normal, homogenized [OPG study]8.2354484
GSM549110patient 046, normal, homogenized [OPG study]8.2630784
GSM549114patient 063, normal, homogenized [OPG study]8.4795684
GSM549122patient 082, normal, homogenized [OPG study]8.8284488
GSM549134patient 033, cancer, homogenized [OPG study]8.3699184
GSM549136patient 036, cancer, homogenized [OPG study]7.7858578
GSM549140patient 044, cancer, homogenized [OPG study]7.5227376
GSM549111patient 047, normal, homogenized [OPG study]8.0620881
GSM549113patient 057, normal, homogenized [OPG study]7.9231480
GSM549132patient 031, cancer, homogenized [OPG study]7.9192180
GSM549137patient 038, cancer, homogenized [OPG study]7.958381
GSM549142patient 047, cancer, homogenized [OPG study]7.2113775
GSM549100patient 110, normal, homogenized [OPG study]8.6594287
GSM549107patient 135, normal, homogenized [OPG study]8.6774686
GSM549115patient 068, normal, homogenized [OPG study]8.0805281
GSM549116patient 072, normal, homogenized [OPG study]7.8638880
GSM549120patient 078, normal, homogenized [OPG study]8.2629883
GSM549131patient 030, cancer, homogenized [OPG study]8.1551682
GSM549118patient 074, normal, homogenized [OPG study]8.0187581
GSM549129patient 027, cancer, homogenized [OPG study]7.6802778
GSM549123patient 088, normal, homogenized [OPG study]7.9018780
GSM549124patient 006, cancer, homogenized [OPG study]7.9221981
GSM549126patient 015, cancer, homogenized [OPG study]7.7580179
GSM549128patient 025, cancer, homogenized [OPG study]6.9342570
GSM549103patient 117, normal, homogenized [OPG study]8.5738687
GSM549117patient 073, normal, homogenized [OPG study]8.7713886
GSM549138patient 041, cancer, homogenized [OPG study]7.4568976
GSM549141patient 045, cancer, homogenized [OPG study]7.6550977
GSM549130patient 028, cancer, homogenized [OPG study]8.3843985
GSM549101patient 111, normal, homogenized [OPG study]8.3410184
GSM549105patient 128, normal, homogenized [OPG study]8.2094583
GSM549106patient 134, normal, homogenized [OPG study]8.2635882
GSM549112patient 048, normal, homogenized [OPG study]8.190283
GSM549125patient 011, cancer, homogenized [OPG study]7.394376
GSM549127patient 024, cancer, homogenized [OPG study]7.6271477
GSM549135patient 035, cancer, homogenized [OPG study]7.846579